Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

In vivo ablation of type I interferon receptor from cardiomyocytes delays coxsackieviral clearance and accelerates myocardial disease.

Althof N, Harkins S, Kemball CC, Flynn CT, Alirezaei M, Whitton JL.

J Virol. 2014 May;88(9):5087-99. doi: 10.1128/JVI.00184-14. Epub 2014 Feb 26.

2.

Wild-type coxsackievirus infection dramatically alters the abundance, heterogeneity, and immunostimulatory capacity of conventional dendritic cells in vivo.

Kemball CC, Flynn CT, Hosking MP, Botten J, Whitton JL.

Virology. 2012 Jul 20;429(1):74-90. doi: 10.1016/j.virol.2012.04.005. Epub 2012 May 1.

3.

Autophagy, inflammation and neurodegenerative disease.

Alirezaei M, Kemball CC, Whitton JL.

Eur J Neurosci. 2011 Jan;33(2):197-204. doi: 10.1111/j.1460-9568.2010.07500.x. Epub 2010 Dec 7. Review.

4.

Coxsackievirus infection induces autophagy-like vesicles and megaphagosomes in pancreatic acinar cells in vivo.

Kemball CC, Alirezaei M, Flynn CT, Wood MR, Harkins S, Kiosses WB, Whitton JL.

J Virol. 2010 Dec;84(23):12110-24. doi: 10.1128/JVI.01417-10. Epub 2010 Sep 22.

5.

Type B coxsackieviruses and their interactions with the innate and adaptive immune systems.

Kemball CC, Alirezaei M, Whitton JL.

Future Microbiol. 2010 Sep;5(9):1329-47. doi: 10.2217/fmb.10.101. Review.

6.

Heterogeneity among viral antigen-specific CD4+ T cells and their de novo recruitment during persistent polyomavirus infection.

Lin E, Kemball CC, Hadley A, Wilson JJ, Hofstetter AR, Pack CD, Lukacher AE.

J Immunol. 2010 Aug 1;185(3):1692-700. doi: 10.4049/jimmunol.0904210. Epub 2010 Jul 9.

7.

Short-term fasting induces profound neuronal autophagy.

Alirezaei M, Kemball CC, Flynn CT, Wood MR, Whitton JL, Kiosses WB.

Autophagy. 2010 Aug;6(6):702-10. Epub 2010 Aug 14.

8.

Coxsackievirus B3 inhibits antigen presentation in vivo, exerting a profound and selective effect on the MHC class I pathway.

Kemball CC, Harkins S, Whitmire JK, Flynn CT, Feuer R, Whitton JL.

PLoS Pathog. 2009 Oct;5(10):e1000618. doi: 10.1371/journal.ppat.1000618. Epub 2009 Oct 16.

9.

Enumeration and functional evaluation of virus-specific CD4+ and CD8+ T cells in lymphoid and peripheral sites of coxsackievirus B3 infection.

Kemball CC, Harkins S, Whitton JL.

J Virol. 2008 May;82(9):4331-42. doi: 10.1128/JVI.02639-07. Epub 2008 Feb 27.

10.

Allogeneic differences in the dependence on CD4+ T-cell help for virus-specific CD8+ T-cell differentiation.

Kemball CC, Szomolanyi-Tsuda E, Lukacher AE.

J Virol. 2007 Dec;81(24):13743-53. Epub 2007 Oct 3.

11.

The antiviral CD8+ T cell response is differentially dependent on CD4+ T cell help over the course of persistent infection.

Kemball CC, Pack CD, Guay HM, Li ZN, Steinhauer DA, Szomolanyi-Tsuda E, Lukacher AE.

J Immunol. 2007 Jul 15;179(2):1113-21.

12.

Continuous recruitment of naive T cells contributes to heterogeneity of antiviral CD8 T cells during persistent infection.

Vezys V, Masopust D, Kemball CC, Barber DL, O'Mara LA, Larsen CP, Pearson TC, Ahmed R, Lukacher AE.

J Exp Med. 2006 Oct 2;203(10):2263-9. Epub 2006 Sep 11.

13.

A mouse model for polyomavirus-associated nephropathy of kidney transplants.

Han Lee ED, Kemball CC, Wang J, Dong Y, Stapler DC Jr, Hamby KM, Gangappa S, Newell KA, Pearson TC, Lukacher AE, Larsen CP.

Am J Transplant. 2006 May;6(5 Pt 1):913-22.

14.

Costimulation requirements for antiviral CD8+ T cells differ for acute and persistent phases of polyoma virus infection.

Kemball CC, Lee ED, Szomolanyi-Tsuda E, Pearson TC, Larsen CP, Lukacher AE.

J Immunol. 2006 Feb 1;176(3):1814-24.

15.

Late priming and variability of epitope-specific CD8+ T cell responses during a persistent virus infection.

Kemball CC, Lee ED, Vezys V, Pearson TC, Larsen CP, Lukacher AE.

J Immunol. 2005 Jun 15;174(12):7950-60.

16.

Cutting edge: rapid in vivo CTL activity by polyoma virus-specific effector and memory CD8+ T cells.

Byers AM, Kemball CC, Moser JM, Lukacher AE.

J Immunol. 2003 Jul 1;171(1):17-21.

17.

Regulation of antiviral CD8+ T cells by inhibitory natural killer cell receptors.

Byers AM, Kemball CC, Andrews NP, Lukacher AE.

Microbes Infect. 2003 Feb;5(2):169-77. Review.

PMID:
12650775
18.

Peptide-independent folding and CD8 alpha alpha binding by the nonclassical class I molecule, thymic leukemia antigen.

Weber DA, Attinger A, Kemball CC, Wigal JL, Pohl J, Xiong Y, Reinherz EL, Cheroutre H, Kronenberg M, Jensen PE.

J Immunol. 2002 Nov 15;169(10):5708-14.

Supplemental Content

Loading ...
Support Center